Framework Nucleic Acid-programmed Aptamer–paclitaxel Conjugates as Targeted Therapeutics for Triple-negative Breast Cancer

Triple-negative breast cancer (TNBC) is highly invasive with a poor prognosis, and chemotherapy remains the clinical treatment of choice. Paclitaxel is a commonly used first-line chemotherapy drug, but its untargeted...